# Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section

> **NCT05807633** · — · COMPLETED · sponsor: **Aesculap AG** · enrollment: 250 (actual)

## Conditions studied

- Cesarean Section Complications
- Cesarean Section; Infection

## Interventions

- **DEVICE:** Novosyn®

## Key facts

- **NCT ID:** NCT05807633
- **Lead sponsor:** Aesculap AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-15
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-10-01
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05807633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05807633, "Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05807633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*